STOCK TITAN

[424B2] Toronto Dominion Bank Prospectus Supplement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B2
Rhea-AI Filing Summary

UBS AG has filed a Rule 424(b)(2) Pricing Supplement for a $2.849 million issuance of Trigger Callable Contingent Yield Notes due 18 July 2030. The notes are unsecured, unsubordinated obligations of UBS AG London Branch and are linked to the least-performing of three equity indices—the Dow Jones Industrial Average (INDU), Nasdaq-100 Technology Sector Index (NDXT) and Russell 2000 (RTY).

Key financial terms

  • Principal: $1,000 per note.
  • Contingent coupon: 8.85% p.a. (paid monthly as $7.375) if all three indices close ≥ 70 % of initial level (“coupon barrier”); otherwise no coupon.
  • Issuer call: Permitted on any monthly observation date after 6 months; if called, holders receive par plus accrued coupon.
  • Downside protection: At maturity, full principal is repaid only if each index ≥ 70 % of initial (“downside threshold”). Otherwise, redemption equals par multiplied by the worst-performing index return, exposing investors to up to 100 % principal loss.
  • Issue price vs. estimated value: $1,000 vs. UBS internal estimate of $964.20 (reflecting fees and hedging costs).
  • Settlement: T+3 trade date 14 Jul 2025; maturity 18 Jul 2030.

Risk highlights

  • Coupon and principal are contingent; investors may receive no income and could lose all capital.
  • Credit exposure to UBS AG; notes are not FDIC-insured.
  • No exchange listing; secondary liquidity depends on dealer support and may be at a significant discount.
  • Correlation risk: performance determined by the weakest index.
  • UBS has discretion to redeem early, creating reinvestment risk when coupons are most attractive.

Use of proceeds & materiality

The $2.8 million size is immaterial to UBS’s capital structure but offers the bank low-cost funding. For investors, the notes provide above-market headline yield in exchange for high equity-market and issuer credit risk.

UBS AG ha presentato un Supplemento di Prezzo ai sensi della Regola 424(b)(2) per un'emissione di 2,849 milioni di dollari di Trigger Callable Contingent Yield Notes con scadenza il 18 luglio 2030. Le obbligazioni sono non garantite e non subordinate, emesse dalla filiale londinese di UBS AG, e sono collegate all'indice azionario con la performance peggiore tra tre: Dow Jones Industrial Average (INDU), Nasdaq-100 Technology Sector Index (NDXT) e Russell 2000 (RTY).

Termini finanziari principali

  • Valore nominale: 1.000 dollari per obbligazione.
  • Coupon condizionato: 8,85% annuo (pagato mensilmente come 7,375 dollari) se tutti e tre gli indici chiudono ≥ 70% del livello iniziale (“barriera coupon”); altrimenti nessun coupon.
  • Opzione di rimborso anticipato dell'emittente: consentita in qualsiasi data di osservazione mensile dopo 6 mesi; se esercitata, i detentori ricevono il valore nominale più il coupon maturato.
  • Protezione al ribasso: alla scadenza, il capitale è rimborsato per intero solo se ogni indice è ≥ 70% del livello iniziale (“soglia ribasso”); altrimenti il rimborso è pari al valore nominale moltiplicato per il rendimento dell'indice peggiore, esponendo gli investitori a una perdita fino al 100% del capitale.
  • Prezzo di emissione vs valore stimato: 1.000 dollari contro la stima interna UBS di 964,20 dollari (inclusi costi di commissione e copertura).
  • Regolamento: T+3 dalla data di negoziazione 14 luglio 2025; scadenza 18 luglio 2030.

Rischi principali

  • Coupon e capitale sono condizionati; gli investitori potrebbero non ricevere alcun reddito e perdere tutto il capitale.
  • Rischio di credito verso UBS AG; le obbligazioni non sono assicurate FDIC.
  • Non quotate in borsa; la liquidità secondaria dipende dal supporto dei dealer e potrebbe essere offerta a sconto significativo.
  • Rischio di correlazione: la performance è determinata dall'indice più debole.
  • UBS può decidere di rimborsare anticipatamente, creando un rischio di reinvestimento quando i coupon sono più interessanti.

Utilizzo dei proventi e rilevanza

La dimensione di 2,8 milioni di dollari è irrilevante per la struttura patrimoniale di UBS ma consente alla banca un finanziamento a basso costo. Per gli investitori, le obbligazioni offrono un rendimento superiore al mercato in cambio di un elevato rischio di mercato azionario e di credito dell'emittente.

UBS AG ha presentado un Suplemento de Precio conforme a la Regla 424(b)(2) para una emisión de 2,849 millones de dólares de Trigger Callable Contingent Yield Notes con vencimiento el 18 de julio de 2030. Las notas son obligaciones no garantizadas y no subordinadas de la sucursal londinense de UBS AG, vinculadas al índice accionario con peor desempeño entre tres índices: Dow Jones Industrial Average (INDU), Nasdaq-100 Technology Sector Index (NDXT) y Russell 2000 (RTY).

Términos financieros clave

  • Principal: 1,000 dólares por nota.
  • Cupón contingente: 8.85% anual (pagado mensualmente como 7.375 dólares) si los tres índices cierran ≥ 70 % del nivel inicial (“barrera de cupón”); de lo contrario, no hay cupón.
  • Opción de llamada del emisor: permitida en cualquier fecha de observación mensual después de 6 meses; si se ejerce, los tenedores reciben el valor nominal más el cupón acumulado.
  • Protección a la baja: al vencimiento, se reembolsa el principal completo solo si cada índice está ≥ 70 % del nivel inicial (“umbral a la baja”); de lo contrario, el reembolso es igual al valor nominal multiplicado por el rendimiento del índice con peor desempeño, exponiendo a los inversores a una pérdida de hasta el 100 % del capital.
  • Precio de emisión vs valor estimado: 1,000 dólares frente a la estimación interna de UBS de 964.20 dólares (que refleja comisiones y costos de cobertura).
  • Liquidación: T+3 desde la fecha de negociación 14 de julio de 2025; vencimiento 18 de julio de 2030.

Aspectos destacados de riesgo

  • El cupón y el principal son condicionales; los inversores podrían no recibir ingresos y podrían perder todo el capital.
  • Exposición crediticia a UBS AG; las notas no están aseguradas por la FDIC.
  • No cotizan en bolsa; la liquidez secundaria depende del soporte de los distribuidores y puede estar a un descuento significativo.
  • Riesgo de correlación: el desempeño está determinado por el índice más débil.
  • UBS tiene la discreción de redimir anticipadamente, lo que genera riesgo de reinversión cuando los cupones son más atractivos.

Uso de los ingresos y materialidad

El tamaño de 2.8 millones de dólares es irrelevante para la estructura de capital de UBS, pero ofrece a la banca financiación de bajo costo. Para los inversores, las notas proporcionan un rendimiento superior al mercado a cambio de un alto riesgo de mercado accionario y de crédito del emisor.

UBS AG는 2030년 7월 18일 만기인 트리거 콜러블 컨틴전트 이율 노트 발행을 위해 규칙 424(b)(2) 가격 보충 자료를 제출했습니다. 이번 발행 규모는 284만 9천 달러이며, UBS AG 런던 지점의 무담보 비후순위 채무입니다. 이 노트는 세 가지 주가지수 중 가장 저조한 성과를 보이는 지수—다우존스 산업평균지수(INDU), 나스닥-100 기술 섹터 지수(NDXT), 러셀 2000(RTY)—와 연동됩니다.

주요 금융 조건

  • 액면가: 노트당 1,000달러.
  • 조건부 쿠폰: 세 지수 모두 초기 수준의 70% 이상으로 마감 시 연 8.85% (월 7.375달러 지급); 그렇지 않으면 쿠폰 없음.
  • 발행자 콜: 6개월 이후 매월 관측일에 콜 가능; 콜 시 보유자는 액면가와 미지급 쿠폰 수령.
  • 하방 보호: 만기 시 각 지수가 초기 수준의 70% 이상일 경우 전액 상환; 그렇지 않으면 최저 성과 지수 수익률에 액면가를 곱한 금액 상환, 최대 100% 원금 손실 가능.
  • 발행가 대비 추정 가치: 1,000달러 대비 UBS 내부 추정가 964.20달러 (수수료 및 헤지 비용 반영).
  • 결제: 2025년 7월 14일 거래일 기준 T+3; 만기 2030년 7월 18일.

위험 요약

  • 쿠폰과 원금은 조건부이며, 투자자는 수익을 받지 못하거나 원금 전액 손실 가능.
  • UBS AG에 대한 신용 위험; FDIC 보험 미적용.
  • 거래소 상장 없음; 2차 유동성은 딜러 지원에 따라 달라지며 상당한 할인 가능성 있음.
  • 상관관계 위험: 성과는 가장 약한 지수에 의해 결정됨.
  • UBS가 조기 상환 권한을 가지며, 쿠폰이 가장 매력적일 때 재투자 위험 발생.

수익금 사용 및 중요성

2.8백만 달러 규모는 UBS 자본 구조에 미미하지만, 은행에는 저비용 자금 조달을 제공합니다. 투자자에게는 높은 주식시장 및 발행자 신용 위험을 감수하는 대가로 시장 대비 높은 명목 수익률을 제공합니다.

UBS AG a déposé un supplément de prix conformément à la règle 424(b)(2) pour une émission de 2,849 millions de dollars de Trigger Callable Contingent Yield Notes arrivant à échéance le 18 juillet 2030. Ces notes sont des obligations non garanties et non subordonnées de la succursale londonienne d’UBS AG, liées à l'indice de performance la plus faible parmi trois indices boursiers : le Dow Jones Industrial Average (INDU), le Nasdaq-100 Technology Sector Index (NDXT) et le Russell 2000 (RTY).

Principaux termes financiers

  • Capital nominal : 1 000 dollars par note.
  • Coupon conditionnel : 8,85 % par an (payé mensuellement à hauteur de 7,375 dollars) si les trois indices clôturent à ≥ 70 % du niveau initial (« barrière de coupon ») ; sinon, aucun coupon.
  • Option de remboursement anticipé de l’émetteur : autorisée à toute date d’observation mensuelle après 6 mois ; si exercée, les porteurs reçoivent la valeur nominale plus le coupon accumulé.
  • Protection à la baisse : à l’échéance, le capital est intégralement remboursé uniquement si chaque indice est ≥ 70 % du niveau initial (« seuil de protection ») ; sinon, le remboursement est égal au nominal multiplié par la performance de l’indice le plus faible, exposant les investisseurs à une perte pouvant atteindre 100 % du capital.
  • Prix d’émission vs valeur estimée : 1 000 dollars contre une estimation interne UBS de 964,20 dollars (incluant frais et coûts de couverture).
  • Règlement : T+3 à partir de la date de transaction du 14 juillet 2025 ; échéance le 18 juillet 2030.

Points clés de risque

  • Coupon et capital sont conditionnels ; les investisseurs peuvent ne recevoir aucun revenu et perdre la totalité du capital.
  • Exposition au risque de crédit d’UBS AG ; les notes ne sont pas assurées par la FDIC.
  • Pas de cotation en bourse ; la liquidité secondaire dépend du soutien des teneurs de marché et peut être proposée avec une décote significative.
  • Risque de corrélation : la performance dépend de l’indice le plus faible.
  • UBS peut décider de rembourser par anticipation, ce qui crée un risque de réinvestissement lorsque les coupons sont les plus attractifs.

Utilisation des fonds et importance

Le montant de 2,8 millions de dollars est insignifiant pour la structure de capital d’UBS mais offre à la banque un financement à faible coût. Pour les investisseurs, ces notes offrent un rendement supérieur au marché en échange d’un risque élevé lié au marché actions et au crédit de l’émetteur.

UBS AG hat einen Pricing Supplement gemäß Rule 424(b)(2) für eine Emission von 2,849 Millionen US-Dollar Trigger Callable Contingent Yield Notes mit Fälligkeit am 18. Juli 2030 eingereicht. Die Notes sind ungesicherte, nicht nachrangige Verbindlichkeiten der UBS AG London Branch und sind an den schwächsten von drei Aktienindizes gekoppelt – den Dow Jones Industrial Average (INDU), Nasdaq-100 Technology Sector Index (NDXT) und Russell 2000 (RTY).

Wesentliche Finanzbedingungen

  • Nennwert: 1.000 US-Dollar pro Note.
  • Bedingter Kupon: 8,85 % p.a. (monatlich 7,375 US-Dollar), zahlbar, wenn alle drei Indizes ≥ 70 % ihres Anfangswerts schließen („Kupon-Barriere“); sonst kein Kupon.
  • Emittenten-Call: Nach 6 Monaten an jedem monatlichen Beobachtungstag möglich; bei Ausübung erhalten Anleger den Nennwert plus aufgelaufenen Kupon.
  • Abwärtsschutz: Bei Fälligkeit wird der volle Nennwert nur zurückgezahlt, wenn jeder Index ≥ 70 % des Anfangswerts liegt („Abwärtsschwelle“); andernfalls erfolgt die Rückzahlung als Nennwert multipliziert mit der Rendite des schlechtesten Index, was einen Totalverlust des Kapitals bedeuten kann.
  • Ausgabepreis vs. geschätzter Wert: 1.000 US-Dollar gegenüber UBS-intern geschätzten 964,20 US-Dollar (inklusive Gebühren und Absicherungskosten).
  • Abwicklung: T+3 ab Handelstag 14. Juli 2025; Fälligkeit 18. Juli 2030.

Risikohighlights

  • Kupon und Kapital sind bedingt; Anleger erhalten möglicherweise keine Erträge und können ihr gesamtes Kapital verlieren.
  • Kreditrisiko gegenüber UBS AG; die Notes sind nicht FDIC-versichert.
  • Keine Börsennotierung; Sekundärliquidität hängt von Händlerunterstützung ab und kann mit erheblichem Abschlag erfolgen.
  • Korrelation: Die Performance wird vom schwächsten Index bestimmt.
  • UBS kann vorzeitig zurückzahlen, was ein Wiederanlagerisiko erzeugt, wenn Kupons am attraktivsten sind.

Verwendung der Erlöse & Bedeutung

Die Größe von 2,8 Millionen US-Dollar ist für die Kapitalstruktur von UBS unerheblich, bietet der Bank jedoch kostengünstige Finanzierung. Für Anleger bieten die Notes eine über dem Markt liegende Rendite als Ausgleich für hohe Aktienmarkt- und Emittentenrisiken.

Positive
  • 8.85 % contingent coupon provides attractive headline yield relative to traditional bonds.
  • Monthly issuer call could return principal early, reducing market exposure if indices stay resilient.
  • 70 % downside threshold offers conditional protection compared with direct equity investment.
Negative
  • Principal at risk: a decline of more than 30 % in any index at maturity triggers proportional loss up to 100 %.
  • Coupon dependency: investors receive no income if any index closes below the 70 % barrier on an observation date.
  • Credit risk: payments rely on UBS AG’s ability to pay; notes are unsecured and uninsured.
  • Estimated value 3.6 % below issue price highlights embedded fees and negative carry for investors.
  • No secondary listing may lead to illiquidity and forced sales at steep discounts.

Insights

TL;DR High 8.85 % coupon but 70 % barriers expose buyers to full downside; small size, neutral for UBS.

The notes combine an equity put and call feature: investors sell downside beyond −30 % on any one of three indices and receive a monthly coupon only when all three remain above their 70 % barriers. The embedded options explain the high advertised yield. Early-call discretion favors UBS—redemption is most likely when coupons are rich and market volatility subsides. The 3.6 % discount between issue price and estimated value signals a heavy fee load. Because the offering totals just $2.8 million, balance-sheet impact on UBS is negligible; the security mainly serves as opportunistic funding. Risk-reward profile is appropriate only for investors seeking leveraged equity income and willing to accept concentrated tail risk and UBS credit exposure.

TL;DR Product offers callable yield but magnifies correlation and liquidity risks; suitability limited.

From a portfolio perspective, contingent yield notes shorten duration via the six-month call window while adding equity beta tied to small-cap and tech factors. The 70 % threshold is relatively tight given historical drawdowns—NDXT fell over 30 % four times in the last decade. Investors bear gap risk on monthly observations; intramonth protection is absent. Lack of listing and possible wide bid-ask spreads impair exit strategies. Given UBS’s A-/Aa credit profile, default risk is low but non-trivial over five years. I view the instrument as neutral overall: potential cash-on-cash yield can enhance income portfolios, yet loss asymmetry and limited liquidity offset benefits.

UBS AG ha presentato un Supplemento di Prezzo ai sensi della Regola 424(b)(2) per un'emissione di 2,849 milioni di dollari di Trigger Callable Contingent Yield Notes con scadenza il 18 luglio 2030. Le obbligazioni sono non garantite e non subordinate, emesse dalla filiale londinese di UBS AG, e sono collegate all'indice azionario con la performance peggiore tra tre: Dow Jones Industrial Average (INDU), Nasdaq-100 Technology Sector Index (NDXT) e Russell 2000 (RTY).

Termini finanziari principali

  • Valore nominale: 1.000 dollari per obbligazione.
  • Coupon condizionato: 8,85% annuo (pagato mensilmente come 7,375 dollari) se tutti e tre gli indici chiudono ≥ 70% del livello iniziale (“barriera coupon”); altrimenti nessun coupon.
  • Opzione di rimborso anticipato dell'emittente: consentita in qualsiasi data di osservazione mensile dopo 6 mesi; se esercitata, i detentori ricevono il valore nominale più il coupon maturato.
  • Protezione al ribasso: alla scadenza, il capitale è rimborsato per intero solo se ogni indice è ≥ 70% del livello iniziale (“soglia ribasso”); altrimenti il rimborso è pari al valore nominale moltiplicato per il rendimento dell'indice peggiore, esponendo gli investitori a una perdita fino al 100% del capitale.
  • Prezzo di emissione vs valore stimato: 1.000 dollari contro la stima interna UBS di 964,20 dollari (inclusi costi di commissione e copertura).
  • Regolamento: T+3 dalla data di negoziazione 14 luglio 2025; scadenza 18 luglio 2030.

Rischi principali

  • Coupon e capitale sono condizionati; gli investitori potrebbero non ricevere alcun reddito e perdere tutto il capitale.
  • Rischio di credito verso UBS AG; le obbligazioni non sono assicurate FDIC.
  • Non quotate in borsa; la liquidità secondaria dipende dal supporto dei dealer e potrebbe essere offerta a sconto significativo.
  • Rischio di correlazione: la performance è determinata dall'indice più debole.
  • UBS può decidere di rimborsare anticipatamente, creando un rischio di reinvestimento quando i coupon sono più interessanti.

Utilizzo dei proventi e rilevanza

La dimensione di 2,8 milioni di dollari è irrilevante per la struttura patrimoniale di UBS ma consente alla banca un finanziamento a basso costo. Per gli investitori, le obbligazioni offrono un rendimento superiore al mercato in cambio di un elevato rischio di mercato azionario e di credito dell'emittente.

UBS AG ha presentado un Suplemento de Precio conforme a la Regla 424(b)(2) para una emisión de 2,849 millones de dólares de Trigger Callable Contingent Yield Notes con vencimiento el 18 de julio de 2030. Las notas son obligaciones no garantizadas y no subordinadas de la sucursal londinense de UBS AG, vinculadas al índice accionario con peor desempeño entre tres índices: Dow Jones Industrial Average (INDU), Nasdaq-100 Technology Sector Index (NDXT) y Russell 2000 (RTY).

Términos financieros clave

  • Principal: 1,000 dólares por nota.
  • Cupón contingente: 8.85% anual (pagado mensualmente como 7.375 dólares) si los tres índices cierran ≥ 70 % del nivel inicial (“barrera de cupón”); de lo contrario, no hay cupón.
  • Opción de llamada del emisor: permitida en cualquier fecha de observación mensual después de 6 meses; si se ejerce, los tenedores reciben el valor nominal más el cupón acumulado.
  • Protección a la baja: al vencimiento, se reembolsa el principal completo solo si cada índice está ≥ 70 % del nivel inicial (“umbral a la baja”); de lo contrario, el reembolso es igual al valor nominal multiplicado por el rendimiento del índice con peor desempeño, exponiendo a los inversores a una pérdida de hasta el 100 % del capital.
  • Precio de emisión vs valor estimado: 1,000 dólares frente a la estimación interna de UBS de 964.20 dólares (que refleja comisiones y costos de cobertura).
  • Liquidación: T+3 desde la fecha de negociación 14 de julio de 2025; vencimiento 18 de julio de 2030.

Aspectos destacados de riesgo

  • El cupón y el principal son condicionales; los inversores podrían no recibir ingresos y podrían perder todo el capital.
  • Exposición crediticia a UBS AG; las notas no están aseguradas por la FDIC.
  • No cotizan en bolsa; la liquidez secundaria depende del soporte de los distribuidores y puede estar a un descuento significativo.
  • Riesgo de correlación: el desempeño está determinado por el índice más débil.
  • UBS tiene la discreción de redimir anticipadamente, lo que genera riesgo de reinversión cuando los cupones son más atractivos.

Uso de los ingresos y materialidad

El tamaño de 2.8 millones de dólares es irrelevante para la estructura de capital de UBS, pero ofrece a la banca financiación de bajo costo. Para los inversores, las notas proporcionan un rendimiento superior al mercado a cambio de un alto riesgo de mercado accionario y de crédito del emisor.

UBS AG는 2030년 7월 18일 만기인 트리거 콜러블 컨틴전트 이율 노트 발행을 위해 규칙 424(b)(2) 가격 보충 자료를 제출했습니다. 이번 발행 규모는 284만 9천 달러이며, UBS AG 런던 지점의 무담보 비후순위 채무입니다. 이 노트는 세 가지 주가지수 중 가장 저조한 성과를 보이는 지수—다우존스 산업평균지수(INDU), 나스닥-100 기술 섹터 지수(NDXT), 러셀 2000(RTY)—와 연동됩니다.

주요 금융 조건

  • 액면가: 노트당 1,000달러.
  • 조건부 쿠폰: 세 지수 모두 초기 수준의 70% 이상으로 마감 시 연 8.85% (월 7.375달러 지급); 그렇지 않으면 쿠폰 없음.
  • 발행자 콜: 6개월 이후 매월 관측일에 콜 가능; 콜 시 보유자는 액면가와 미지급 쿠폰 수령.
  • 하방 보호: 만기 시 각 지수가 초기 수준의 70% 이상일 경우 전액 상환; 그렇지 않으면 최저 성과 지수 수익률에 액면가를 곱한 금액 상환, 최대 100% 원금 손실 가능.
  • 발행가 대비 추정 가치: 1,000달러 대비 UBS 내부 추정가 964.20달러 (수수료 및 헤지 비용 반영).
  • 결제: 2025년 7월 14일 거래일 기준 T+3; 만기 2030년 7월 18일.

위험 요약

  • 쿠폰과 원금은 조건부이며, 투자자는 수익을 받지 못하거나 원금 전액 손실 가능.
  • UBS AG에 대한 신용 위험; FDIC 보험 미적용.
  • 거래소 상장 없음; 2차 유동성은 딜러 지원에 따라 달라지며 상당한 할인 가능성 있음.
  • 상관관계 위험: 성과는 가장 약한 지수에 의해 결정됨.
  • UBS가 조기 상환 권한을 가지며, 쿠폰이 가장 매력적일 때 재투자 위험 발생.

수익금 사용 및 중요성

2.8백만 달러 규모는 UBS 자본 구조에 미미하지만, 은행에는 저비용 자금 조달을 제공합니다. 투자자에게는 높은 주식시장 및 발행자 신용 위험을 감수하는 대가로 시장 대비 높은 명목 수익률을 제공합니다.

UBS AG a déposé un supplément de prix conformément à la règle 424(b)(2) pour une émission de 2,849 millions de dollars de Trigger Callable Contingent Yield Notes arrivant à échéance le 18 juillet 2030. Ces notes sont des obligations non garanties et non subordonnées de la succursale londonienne d’UBS AG, liées à l'indice de performance la plus faible parmi trois indices boursiers : le Dow Jones Industrial Average (INDU), le Nasdaq-100 Technology Sector Index (NDXT) et le Russell 2000 (RTY).

Principaux termes financiers

  • Capital nominal : 1 000 dollars par note.
  • Coupon conditionnel : 8,85 % par an (payé mensuellement à hauteur de 7,375 dollars) si les trois indices clôturent à ≥ 70 % du niveau initial (« barrière de coupon ») ; sinon, aucun coupon.
  • Option de remboursement anticipé de l’émetteur : autorisée à toute date d’observation mensuelle après 6 mois ; si exercée, les porteurs reçoivent la valeur nominale plus le coupon accumulé.
  • Protection à la baisse : à l’échéance, le capital est intégralement remboursé uniquement si chaque indice est ≥ 70 % du niveau initial (« seuil de protection ») ; sinon, le remboursement est égal au nominal multiplié par la performance de l’indice le plus faible, exposant les investisseurs à une perte pouvant atteindre 100 % du capital.
  • Prix d’émission vs valeur estimée : 1 000 dollars contre une estimation interne UBS de 964,20 dollars (incluant frais et coûts de couverture).
  • Règlement : T+3 à partir de la date de transaction du 14 juillet 2025 ; échéance le 18 juillet 2030.

Points clés de risque

  • Coupon et capital sont conditionnels ; les investisseurs peuvent ne recevoir aucun revenu et perdre la totalité du capital.
  • Exposition au risque de crédit d’UBS AG ; les notes ne sont pas assurées par la FDIC.
  • Pas de cotation en bourse ; la liquidité secondaire dépend du soutien des teneurs de marché et peut être proposée avec une décote significative.
  • Risque de corrélation : la performance dépend de l’indice le plus faible.
  • UBS peut décider de rembourser par anticipation, ce qui crée un risque de réinvestissement lorsque les coupons sont les plus attractifs.

Utilisation des fonds et importance

Le montant de 2,8 millions de dollars est insignifiant pour la structure de capital d’UBS mais offre à la banque un financement à faible coût. Pour les investisseurs, ces notes offrent un rendement supérieur au marché en échange d’un risque élevé lié au marché actions et au crédit de l’émetteur.

UBS AG hat einen Pricing Supplement gemäß Rule 424(b)(2) für eine Emission von 2,849 Millionen US-Dollar Trigger Callable Contingent Yield Notes mit Fälligkeit am 18. Juli 2030 eingereicht. Die Notes sind ungesicherte, nicht nachrangige Verbindlichkeiten der UBS AG London Branch und sind an den schwächsten von drei Aktienindizes gekoppelt – den Dow Jones Industrial Average (INDU), Nasdaq-100 Technology Sector Index (NDXT) und Russell 2000 (RTY).

Wesentliche Finanzbedingungen

  • Nennwert: 1.000 US-Dollar pro Note.
  • Bedingter Kupon: 8,85 % p.a. (monatlich 7,375 US-Dollar), zahlbar, wenn alle drei Indizes ≥ 70 % ihres Anfangswerts schließen („Kupon-Barriere“); sonst kein Kupon.
  • Emittenten-Call: Nach 6 Monaten an jedem monatlichen Beobachtungstag möglich; bei Ausübung erhalten Anleger den Nennwert plus aufgelaufenen Kupon.
  • Abwärtsschutz: Bei Fälligkeit wird der volle Nennwert nur zurückgezahlt, wenn jeder Index ≥ 70 % des Anfangswerts liegt („Abwärtsschwelle“); andernfalls erfolgt die Rückzahlung als Nennwert multipliziert mit der Rendite des schlechtesten Index, was einen Totalverlust des Kapitals bedeuten kann.
  • Ausgabepreis vs. geschätzter Wert: 1.000 US-Dollar gegenüber UBS-intern geschätzten 964,20 US-Dollar (inklusive Gebühren und Absicherungskosten).
  • Abwicklung: T+3 ab Handelstag 14. Juli 2025; Fälligkeit 18. Juli 2030.

Risikohighlights

  • Kupon und Kapital sind bedingt; Anleger erhalten möglicherweise keine Erträge und können ihr gesamtes Kapital verlieren.
  • Kreditrisiko gegenüber UBS AG; die Notes sind nicht FDIC-versichert.
  • Keine Börsennotierung; Sekundärliquidität hängt von Händlerunterstützung ab und kann mit erheblichem Abschlag erfolgen.
  • Korrelation: Die Performance wird vom schwächsten Index bestimmt.
  • UBS kann vorzeitig zurückzahlen, was ein Wiederanlagerisiko erzeugt, wenn Kupons am attraktivsten sind.

Verwendung der Erlöse & Bedeutung

Die Größe von 2,8 Millionen US-Dollar ist für die Kapitalstruktur von UBS unerheblich, bietet der Bank jedoch kostengünstige Finanzierung. Für Anleger bieten die Notes eine über dem Markt liegende Rendite als Ausgleich für hohe Aktienmarkt- und Emittentenrisiken.


The information in this preliminary pricing supplement is not complete and may be changed. We may not sell these Buffered PLUS until the pricing supplement, the accompanying product supplement, underlier supplement and prospectus (collectively, the “Offering Documents”) are delivered in final form. The Offering Documents are not an offer to sell these Buffered PLUS and we are not soliciting offers to buy these Buffered PLUS in any state where the offer or sale is not permitted.
Subject to Completion
July 2025
Preliminary Pricing Supplement
Dated July 15, 2025
Registration Statement No. 333-283969
Filed pursuant to Rule 424(b)(2)
(To Prospectus dated February 26, 2025
Underlier Supplement dated February 26, 2025 and Product Supplement MLN-EI-1 dated February 26, 2025)
STRUCTURED INVESTMENTS
Opportunities in International Equities
Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
The Dual Directional Buffered PLUS or “Buffered PLUS” will pay no interest and provide a minimum payment at maturity of only 15.00% of the stated principal amount. At maturity, if the final index value of the underlying index is greater than the initial index value, investors will receive the stated principal amount of their investment plus the leveraged upside performance of the underlying index, subject to the maximum payment at maturity. If the final index value is less than or equal to the initial index value, but not by more than the buffer amount of 15.00%, investors will receive at maturity the stated principal amount of their investment plus an unleveraged positive return equal to the absolute value of the percentage decline, which will effectively be limited to a positive 15.00% return. However, if the final index value is less than the initial index value by more than the buffer amount, investors will lose 1% for every 1% that the final index value falls below the initial index value in excess of the buffer amount and could lose up to 85.00% of the stated principal amount. Accordingly, the Buffered PLUS do not guarantee the full return of principal at maturity and you could lose up to 85.00% of your investment in the Buffered PLUS. The Buffered PLUS are for investors who seek an index-based return and who are willing to risk their principal and forgo current income and upside above the maximum payment at maturity in exchange for the upside leverage, buffer and absolute return features that, in each case, apply to a limited range of performance of the underlying index. The Buffered PLUS are senior unsecured debt securities issued by The Toronto-Dominion Bank (“TD” or “we”). The Buffered PLUS are notes issued as part of TD’s Senior Debt Securities, Series H.
All payments on the Buffered PLUS are subject to the credit risk of TD. If TD were to default on its payment obligations, you may not receive any amounts owed to you under the Buffered PLUS and you could lose your entire investment in the Buffered PLUS. These Buffered PLUS are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.
 
SUMMARY TERMS
 
Issuer:
The Toronto-Dominion Bank (“TD”)
 
Issue:
Senior Debt Securities, Series H
 
Underlying index:
EURO STOXX 50® Index (Bloomberg Ticker: “SX5E”)
 
Aggregate principal amount:
$•
 
Stated principal amount:
$1,000.00 per Buffered PLUS
 
Issue price:
$1,000.00 per Buffered PLUS (see “Commissions and issue price” below)
 
Minimum investment:
$1,000.00 (1 Buffered PLUS)
 
Coupon:
None
 
Pricing date:
July 31, 2025
 
Original issue date:
August 5, 2025 (3 business days after the pricing date). Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day (T+1), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Buffered PLUS in the secondary market on any date prior to one business day before delivery of the Buffered PLUS will be required, by virtue of the fact that the Buffered PLUS initially will settle in three business days (T+3), to specify alternative settlement arrangements to prevent a failed settlement of the secondary market trade.
 
Valuation date:
July 30, 2027, subject to postponement in the event of a market disruption event as described in the accompanying product supplement
 
Maturity date:
August 4, 2027, subject to postponement in the event of a market disruption event, as described in the accompanying product supplement
 
Payment at maturity per Buffered
PLUS:
    If the final index value is greater than the initial index value:
$1,000.00 + leveraged upside payment
In no event will the payment at maturity exceed the maximum payment at maturity.
    If the final index value is less than or equal to the initial index value, but not by more than the buffer amount:
$1,000.00 + ($1,000.00 × absolute underlying return)
In this scenario, you will receive a 1% positive return on the Buffered PLUS for each 1% negative return on the underlying index. In no event will this amount exceed the stated principal amount plus $150.00. You will not benefit from the leverage feature in this scenario.
    If the final index value is less than the initial index value by more than the buffer amount
$1,000.00 + [$1,000.00 × (underlying return + buffer amount)]
If the final index value is less than the initial index value by more than the buffer amount, you will lose 1% for every 1% that the final index value falls below the initial index value in excess of the buffer amount and could lose up to 85.00% of your investment in the Buffered PLUS.
 
Underlying return:
(final index value − initial index value) / initial index value
 
Absolute underlying return:
The absolute value of the underlying return. For example, a -5% underlying return will result in a +5% absolute underlying return.
 
Leverage factor:
150%
 
Leveraged upside payment:
$1,000.00 × leverage factor × underlying return
 
Buffer amount:
15.00%
 
Maximum gain:
20.40%
 
Maximum payment at maturity:
$1,204.00 per Buffered PLUS (120.40% of the stated principal amount)
 
Initial index value:
The index closing value of the underlying index on the pricing date, as determined by the calculation agent and as may be adjusted as described under “General Terms of the Notes — Unavailability of the Level of, or Change in Law Event Affecting, the Reference Asset; Modification to Method of Calculation”, as described in the accompanying product supplement.
 
Final index value:
The index closing value of the underlying index on the valuation date, as determined by the calculation agent and as may be adjusted as described under “General Terms of the Notes — Unavailability of the Level of, or Change in Law Event Affecting, the Reference Asset; Modification to Method of Calculation”, as described in the accompanying product supplement.
 
CUSIP/ISIN:
89115HL21 / US89115HL218
 
Listing:
The Buffered PLUS will not be listed or displayed on any securities exchange or any electronic communications network.
 
Calculation agent:
TD
 
Agent:
TD Securities (USA) LLC (“TDS”), an affiliate of TD. See Additional Information About the Buffered PLUSSupplemental information regarding plan of distribution (conflicts of interest); secondary markets (if any).”
 
Estimated value on the pricing
date:  
The estimated value of your Buffered PLUS at the time the terms of your Buffered PLUS will be set on the pricing date is expected to be between $930.00 and $965.00 per Buffered PLUS, as discussed further under “Risk Factors — Risks Relating to Estimated Value and Liquidity” beginning on page 10 and “Additional Information About the Buffered PLUS — Additional information regarding the estimated value of the Buffered PLUS” herein. The estimated value is expected to be less than the public offering price of the Buffered PLUS.
 
Commissions and issue price:
Price to Public(1)
Fees and Commissions(1)
Proceeds to Issuer
 
Per Buffered PLUS:
$1,000.00
   $20.00(a)
+  $5.00(b)
 $25.00
$975.00
 
Total:
$•
$•
$•
(1)
TDS will purchase the Buffered PLUS from TD at the price to public less a fee of $25.00 per Buffered PLUS. TDS will resell all of the Buffered PLUS to Morgan Stanley Smith Barney LLC (“Morgan Stanley Wealth Management”) at an underwriting discount which reflects:
  (a)
a fixed sales commission of $20.00 per $1,000.00 stated principal amount of Buffered PLUS that Morgan Stanley Wealth Management sells and
  (b)
a fixed structuring fee of $5.00 per $1,000.00 stated principal amount of Buffered PLUS that Morgan Stanley Wealth Management sells,
each payable to Morgan Stanley Wealth Management. See “Additional Information About the Buffered PLUS — Supplemental information regarding plan of distribution (conflicts of interest); secondary markets (if any)” herein.
The Buffered PLUS involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 8.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these Buffered PLUS or determined that this pricing supplement, the product supplement, the underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The Buffered PLUS are unsecured and are not savings accounts or insured deposits of a bank. The Buffered PLUS are not insured or guaranteed by the Canada Deposit Insurance Corporation, the U.S. Federal Deposit Insurance Corporation or any other governmental agency or instrumentality of Canada or the United States. The Buffered PLUS will not be listed or displayed on any securities exchange or electronic communications network.
We will deliver the Buffered PLUS in book-entry only form through the facilities of The Depository Trust Company on the original issue date against payment in immediately available funds.

Product supplement dated February 26, 2025
Underlier supplement dated February 26, 2025
Prospectus dated February 26, 2025


Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Additional Information About TD and the Buffered PLUS
You should read this pricing supplement together with the prospectus dated February 26, 2025, as supplemented by the product supplement MLN-EI-1 dated February 26, 2025 and the underlier supplement dated February 26, 2025, relating to our Senior Debt Securities, Series H, of which these Buffered PLUS are a part. Capitalized terms used but not defined in this pricing supplement will have the meanings given to them in the product supplement. In the event of any conflict the following hierarchy will govern: first, this pricing supplement; second, the product supplement; third, the underlier supplement; and last, the accompanying prospectus. The Buffered PLUS vary from the terms described in the product supplement in several important ways. You should read this pricing supplement carefully.
This pricing supplement, together with the documents listed below, contains the terms of the Buffered PLUS and supersedes all prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth in “Risk Factors” herein, “Additional Risk Factors Specific to the Notes” in the product supplement and in “Risk Factors” in the prospectus, as the Buffered PLUS involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Buffered PLUS. You may access these documents on the SEC website at www.sec.gov as follows (or if that address has changed, by reviewing our filings for the relevant date on the SEC website):
Prospectus dated February 26, 2025:
http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm
Underlier Supplement dated February 26, 2025:
http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm
Product Supplement MLN-EI-1 dated February 26, 2025:
http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm
Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, “TD,” “we,” “us,” or “our” refers to The Toronto-Dominion Bank and its subsidiaries.
TD reserves the right to change the terms of, or reject any offer to purchase, the Buffered PLUS prior to their issuance. In the event of any changes to the terms of the Buffered PLUS, TD will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case TD may reject your offer to purchase.
“Buffered Performance Leveraged Upside SecuritiesSM” and “Buffered PLUSSM” are service marks of Morgan Stanley.

July 2025
Page 2

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Investment Overview
Dual Directional Buffered Performance Leveraged Upside Securities
Principal at Risk Securities
The Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027 can be used:
As an alternative to direct exposure to the underlying index that enhances returns for a certain range of positive performance of the underlying index, subject to the maximum payment at maturity; however, by investing in the Buffered PLUS, you will not be entitled to receive any dividends paid with respect to the stocks comprising the underlying index (the “index constituent stocks”) or any interest payments, and your return will not exceed the maximum payment at maturity. You should carefully consider whether an investment that does not provide for any dividends, interest payments or exposure to the positive performance of the underlying index beyond a value that, when multiplied by the leverage factor, exceeds the maximum gain is appropriate for you.
To enhance returns and potentially outperform the underlying index in a moderately bullish scenario.
To achieve similar levels of upside exposure to the underlying index as a direct investment, subject to the maximum payment at maturity, while using fewer dollars by taking advantage of the leverage factor.
To provide an unleveraged positive return for a limited range of negative performance of the underlying index.
To obtain a buffer against a specified percentage of negative performance of the value of the underlying index.

Maturity:
Approximately 24 months
Leverage factor:
150% (applicable only if the final index value is greater than the initial index value)
Buffer amount:
15.00%
Maximum payment at maturity:
$1,204.00 per Buffered PLUS (120.40% of the stated principal amount)
Maximum gain:
20.40%
Coupon:
None
Minimum payment at maturity:
$150.00 (15.00% of the stated principal amount).
Listing:
The Buffered PLUS will not be listed or displayed on any securities exchange or any electronic communications network.

July 2025
Page 3

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Key Investment Rationale
Investors can use the Buffered PLUS to leverage upside returns by 150%, up to the maximum gain and, through the absolute return feature, to earn an unleveraged positive return for a limited range of negative performance of the underlying index. If the final index value is greater than the initial index value, investors will receive the stated principal amount of their investment plus the leveraged upside performance of the underlying index, subject to the maximum payment at maturity. If the final index value is less than or equal to the initial index value, but not by more than the buffer amount of 15.00%, investors will receive the stated principal amount of their investment plus an unleveraged positive return equal to the absolute value of the percentage decline, which will effectively be limited to a positive 15.00% return. However, if the final index value is less than the initial index value by more than the buffer amount, investors will lose 1% for every 1% that the final index value falls below the initial index value in excess of the buffer amount. Investors may lose up to 85.00% of their investment in the Buffered PLUS. All payments on the Buffered PLUS are subject to the credit risk of TD. If TD becomes unable to meet its financial obligations as they become due, investors may not receive any amounts due under the terms of the Buffered PLUS.
Investors will not be entitled to receive any dividends paid with respect to the index constituent stocks and the Buffered PLUS do not pay periodic interest. You should carefully consider whether an investment that does not provide for any dividends or periodic interest is appropriate for you.
 
Leveraged Upside Performance Up to a Cap
 
The Buffered PLUS offer investors an opportunity to capture enhanced returns for a certain range of positive performance relative to a direct investment in the underlying index or the index constituent stocks.
 
 
 
Absolute Return Feature
 
The Buffered PLUS offer investors an opportunity to earn a positive return if the final index value is less than or equal to the initial index value but not by more than the buffer amount.
 
 
 
Upside Scenario
 
If the final index value is greater than the initial index value, at maturity you will receive the stated principal amount of $1,000.00 plus the leveraged upside payment, subject to the maximum payment at maturity of $1,204.00 per Buffered PLUS (120.40% of the stated principal amount).
       
 
Absolute Return Scenario
 
If the final index value is less than or equal to the initial index value, but not by more than the buffer amount, at maturity you will receive a 1% positive return for each 1% negative return of the underlying index. For example, if the final index value is 5% less than the initial index value, the Buffered PLUS will provide a total positive return of 5% at maturity. The maximum return you may receive in this scenario is a positive 15.00% return at maturity.
       
 
Downside Scenario
 
If the final index value is less than the initial index value by more than the buffer amount, at maturity you will receive less than the stated principal amount and you will lose 1% for every 1% that the final index value has fallen below the initial index value in excess of the buffer amount. For example, if the underlying return is -45%, each Buffered PLUS will redeem for $700.00, or 70% of the stated principal amount. The minimum payment at maturity on the Buffered PLUS is 15.00% of the stated principal amount and you could lose up to 85.00% of your investment in the Buffered PLUS.

July 2025
Page 4

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Investor Suitability
The Buffered PLUS may be suitable for you if:
You fully understand and are willing to accept the risks of an investment in the Buffered PLUS, including the risk that you may lose up to 85.00% of your investment in the Buffered PLUS
You can tolerate a loss of some and up to 85.00% of your investment and are willing to make an investment that, if the final index value is less than the initial index value by more than the buffer amount, has similar downside market risk as that of a direct investment in the underlying index or the index constituent stocks
You believe that the final index value will be greater than the initial index value and you understand and accept that any upside return that you earn on the Buffered PLUS will not exceed the maximum gain
You believe that the final index value will be less than the initial index value by not more than the buffer amount and you accept that any decrease in the final index value from the initial index value by more than the buffer amount will result in a loss, rather than a positive return, on your investment
You can tolerate fluctuations in the market prices of the Buffered PLUS prior to maturity that may be similar to or exceed the fluctuations in the value of the underlying index
You do not seek current income from your investment and are willing to forgo any dividends paid on the index constituent stocks
You are willing and able to hold the Buffered PLUS to maturity, a term of approximately 24 months, and accept that there may be little or no secondary market for the Buffered PLUS
You understand and are willing to accept the risks associated with the underlying index
You are willing to assume the credit risk of TD for all payments under the Buffered PLUS, and you understand that if TD defaults on its obligations you may not receive any amounts due to you including any repayment of principal
The Buffered PLUS may not be suitable for you if:
You do not fully understand or are unwilling to accept the risks of an investment in the Buffered PLUS, including the risk that you may lose up to 85.00% of your investment in the Buffered PLUS
You require an investment that provides for full protection against loss of principal
You are not willing to make an investment that, if the final index value is less than the initial index value by more than the buffer amount, has similar downside market risk as that of a direct investment in the underlying index or the index constituent stocks
You believe that the final index value will be less than the initial index value by more than the buffer amount
You seek an investment that has an unlimited return potential or you do not understand or cannot accept that your potential upside return on the Buffered PLUS is limited to the maximum gain or that your potential positive return from the absolute return feature is limited by the buffer amount
You cannot tolerate fluctuations in the market price of the Buffered PLUS prior to maturity that may be similar to or exceed the fluctuations in the value of the underlying index
You seek current income from your investment or prefer to receive the dividends paid on the index constituent stocks
You are unable or unwilling to hold the Buffered PLUS to maturity, a term of approximately 24 months, or seek an investment for which there will be an active secondary market
You do not understand or are not willing to accept the risks associated with the underlying index
You are not willing to assume the credit risk of TD for all payments under the Buffered PLUS, including any repayment of principal

July 2025
Page 5

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
How the Dual Directional Buffered PLUS Work
Hypothetical Examples
The below examples are based on the following terms and are purely hypothetical (the actual terms of your Buffered PLUS will be determined on the pricing date and will be specified in the final pricing supplement):
Investors will not be entitled to receive any dividends paid with respect to the index constituent stocks or any periodic interest. You should carefully consider whether an investment that does not provide for any dividends or periodic interest is appropriate for you. All payments on the Buffered PLUS are subject to our credit risk.
Stated principal amount:
$1,000.00 per Buffered PLUS
Leverage factor:
150%
Buffer amount:
15.00%
Hypothetical initial index value:
100.00
Maximum payment at maturity:
$1,204.00 per Buffered PLUS
Maximum gain:
20.40%
Minimum payment at maturity:
$150.00 (15.00% of the stated principal amount)
EXAMPLE 1: The value of the underlying index increases over the term of the Buffered PLUS.
Final index value
103.00
Underlying return
(103.00 – 100.00) / 100.00 = 3.00%
Payment at maturity
= $1,000.00 + leveraged upside payment, subject to the maximum payment at maturity

= $1,000.00 + ($1,000.00 × leverage factor × underlying return), subject to the maximum payment at maturity

= $1,000.00 + ($1,000.00 × 150% × 3.00%), subject to the maximum payment at maturity

= $1,045.00
In Example 1, the final index value is greater than the initial index value and the underlying return is 3.00%. Accordingly, investors receive the stated principal amount at maturity plus a return equal to 150% times the underlying return, resulting in a payment at maturity of $1,045.00 per Buffered PLUS (a total return of 4.50%).
EXAMPLE 2: The value of the underlying index increases over the term of the Buffered PLUS such that the payment at maturity is equal to the maximum payment at maturity.
Final index value
150.00
Underlying return
(150.00 – 100.00) / 100.00 = 50.00%
Payment at maturity
= $1,000.00 + leveraged upside payment, subject to the maximum payment at maturity

= $1,000.00 + ($1,000.00 × leverage factor × underlying return), subject to the maximum payment at maturity

= maximum payment at maturity of $1,204.00 per Buffered PLUS
In Example 2, the final index value is greater than the initial index value and the underlying return is 50.00%. Under the terms of the Buffered PLUS, investors will realize the maximum payment at maturity if the underlying return is 13.60% or higher. Therefore, in this example, investors receive the maximum payment at maturity of $1,204.00 per stated principal amount, even though the underlying index has appreciated by an amount significantly greater than the return represented by the maximum payment at maturity.

July 2025
Page 6

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
EXAMPLE 3: The final index value is less than the initial index value, but not by more than the buffer amount.
Final index value
95.00
Underlying return
(95.00 – 100.00) / 100.00 = -5.00%
Payment at maturity
= $1,000.00 + ($1,000.00 × absolute underlying return)

= $1,000.00 + ($1,000.00 × |-5.00%|)

= $1,050.00
In Example 3, the final index value is less than the initial index value and the underlying return is-5.00%. Accordingly, investors receive the stated principal amount at maturity plus an unleveraged positive return equal to the absolute value of the percentage decline, resulting in a payment at maturity of $1,050.00 per Buffered PLUS (a total return of 5.00%).
EXAMPLE 4: The final index value is less than the initial index value by more than the buffer amount.
Final index value
40.00
Underlying return
(40.00 – 100.00) / 100.00 = -60.00%
Payment at maturity
= $1,000.00 + [$1,000.00 × (underlying return + buffer amount)]
 
= $1,000.00 + [$1,000.00 × (-60.00% + 15.00%)]

= $1,000.00 - $450.00

= $550.00
In Example 4, the final index value is less than the initial index value and the underlying return is -60.00%. Because the final index value is less than the initial index value by more than the buffer amount, investors receive a payment at maturity of $550.00 per Buffered PLUS (a return on investment of -45.00%).
If the final index value is less than the initial index value by more than the buffer amount, you will lose 1% for every 1% that the final index value falls below the initial index value in excess of the buffer amount and could lose up to 85.00% of your investment in the Buffered PLUS.

July 2025
Page 7

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Risk Factors
The following is a non-exhaustive list of certain key risk factors for investors in the Buffered PLUS. For further discussion of these and other risks, you should read the section entitled “Additional Risk Factors Specific to the Notes” of the accompanying product supplement and “Risk Factors” of the accompanying prospectus. We also urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Buffered PLUS.
Risks Relating to Return Characteristics
You may lose up to 85.00% of your investment in the Buffered PLUS. The Buffered PLUS differ from ordinary debt securities in that TD will not necessarily repay the stated principal amount of the Buffered PLUS at maturity. If the final index value is less than the initial index value by more than the buffer amount, you will lose 1% of your principal for every 1% that the final index value falls below the initial index value in excess of the buffer amount. You may lose up to 85.00% of your investment in the Buffered PLUS.
The stated payout from the issuer applies only at maturity. You should be willing to hold your Buffered PLUS to maturity. The stated payout, including the potential to benefit from the upside leverage and absolute return features, is available only if you hold your Buffered PLUS to maturity. If you are able to sell your Buffered PLUS prior to maturity in the secondary market, you may have to sell them at a loss relative to your investment in the Buffered PLUS even if the then-current value of the underlying index is less than the initial index value but not by more than the buffer amount.
The potential positive return on the Buffered PLUS from any negative performance of the underlying index is limited by the buffer amount and the return on the Buffered PLUS may change significantly despite only a small difference in the degree of change of the final index value relative to the initial index value. If the final index value is less than or equal to the initial index value but not by more than the buffer amount, you will receive at maturity $1,000 plus a return equal to the absolute underlying return, which will reflect a 1% positive return for each 1% negative return on the underlying index. You will not benefit from the leverage feature in this scenario. However, due to the buffer amount, your return from the absolute return feature is effectively limited to 15.00% and the return on the Buffered PLUS may change significantly despite only a small difference in the degree of change of the final index value relative to the initial index value. While a decline from the initial index value to the final index value by a percentage that is less than or equal to buffer amount will result in a positive return equal to the absolute underlying return, a decline by more than the buffer amount would instead result in a loss of 1% of your principal for every 1% that the final index value falls below the initial index value in excess of the buffer amount. The return on the Buffered PLUS in these two scenarios is significantly different despite only a small relative difference in the underlying return.
Your potential return on the Buffered PLUS is limited to the maximum gain. The return potential of the Buffered PLUS is limited to the maximum gain. Therefore, you will not benefit from any positive underlying return in excess of an amount that, when multiplied by the leverage factor, exceeds the maximum gain. Your return on the Buffered PLUS may be less than that of a hypothetical direct investment in the underlying index or the index constituent stocks.
You will not receive any interest payments. TD will not pay any interest with respect to the Buffered PLUS.
The amount payable on the Buffered PLUS is not linked to the value of the underlying index at any time other than the valuation date. The final index value will be based on the index closing value on the valuation date, subject to postponement for non-trading days and certain market disruption events. If the value of the underlying index falls on the valuation date, the payment at maturity may be significantly less than it would have been had the payment at maturity been linked to the value of the underlying index at any time prior to such drop. Although the index closing value on the maturity date or at other times during the term of the Buffered PLUS may be more favorable to you than the index closing value on the valuation date, the payment at maturity will be based solely on the index closing value on the valuation date.
Owning the Buffered PLUS is not the same as owning the index constituent stocks. The return on your Buffered PLUS may not reflect the return you would realize if you actually owned the index constituent stocks. For instance, you will not benefit from any positive underlying return in excess of an amount that, when multiplied by the leverage factor, exceeds the maximum gain. Furthermore, you will not receive or be entitled to receive any dividend payments or other distributions paid on the index constituent stocks, and any such dividends or distributions will not be factored into the calculation of the payment at maturity on your Buffered PLUS. In addition, as an owner of the Buffered PLUS, you will not have voting rights or any other rights that a holder of the index constituent stocks may have.

July 2025
Page 8

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
The absolute return feature is not the same as taking a short position directly in the underlying index or any index constituent stocks. The return on your Buffered PLUS will not reflect the return you may realize if you actually took a short position directly in the underlying index or any index constituent stocks. Unlike a direct short position in the underlying index or the index constituent stocks, which would entitle you to fully benefit from any depreciation of the underlying index or such index constituent stocks, you will not benefit from any depreciation of the underlying index beyond an underlying return of -15.00%. To the contrary, an underlying return of less than -15.00% will result in a loss of 1% of your principal for every 1% that the final index value falls below the initial index value in excess of the buffer amount, and you could lose up to 85.00% of your investment in the Buffered PLUS, as described above.
Risks Relating to Characteristics of the Underlying Index
An investment in the Buffered PLUS involves market risk associated with the underlying index. The return on the Buffered PLUS, which may be negative, is linked to the performance of the underlying index and indirectly linked to the value of the index constituent stocks. The value of the underlying index can rise or fall sharply due to factors specific to the underlying index or its index constituent stocks and their issuers (the “index constituent stock issuers”), such as stock or commodity price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors, such as general stock market or commodity market volatility and values, interest rates and economic, political and other conditions. You, as an investor in the Buffered PLUS, should make your own investigation into the underlying index and the index constituent stocks.
There can be no assurance that the investment view implicit in the Buffered PLUS will be successful. It is impossible to predict whether and the extent to which the value of the underlying index will rise or fall and there can be no assurance that the final index value will not be less than the initial index value by more than the buffer amount. The final index value (and therefore the underlying return) will be influenced by complex and interrelated political, economic, financial and other factors that affect the index constituent stock issuers. You should be willing to accept the risks associated with the relevant markets tracked by the underlying index in general and each index constituent stock in particular, and the risk of losing some and up to 85.00% of your investment in the Buffered PLUS.
The underlying index reflects price return, not total return. The return on the Buffered PLUS is based on the performance of the underlying index, which reflects the changes in the market prices of the index constituent stocks. It is not, however, linked to a “total return” index or strategy, which, in addition to reflecting those price returns, would also reflect any dividends paid on the index constituent stocks. The return on the Buffered PLUS will not include such a total return feature or dividend component.
The Buffered PLUS will not be adjusted for changes in exchange rates related to the U.S. dollar. Although the index constituent stocks trade in euros, the Buffered PLUS are denominated in U.S. dollars. The calculation of the amount payable on the Buffered PLUS at maturity will not be adjusted for changes in the exchange rates between the U.S. dollar and the euro. Changes in exchange rates, however, may reflect changes in various non-U.S. economies that in turn may affect the value of the underlying index and, accordingly, the amount payable on the Buffered PLUS. You will not benefit from any appreciation of the euro relative to the U.S. dollar, which you would have had you owned such stocks directly.
The Buffered PLUS are subject to non-U.S. securities market risk. The underlying index is subject to risks associated with non-U.S. securities markets, specifically that of the Eurozone. An investment in securities, such as the Buffered PLUS, linked directly or indirectly to the value of securities issued by non-U.S. companies involves particular risks. Generally, non-U.S. securities markets may be more volatile than U.S. securities markets, and market developments may affect non-U.S. markets differently than U.S. securities markets. Direct or indirect government intervention to stabilize these non-U.S. markets, as well as cross shareholdings in non-U.S. companies, may affect trading prices and volumes in those markets. There is generally less publicly available information about non-U.S. companies than about those U.S. companies that are subject to the reporting requirements of the SEC, and non-U.S. companies are subject to accounting, auditing and financial reporting standards and requirements that differ from those applicable to U.S. reporting companies. Securities prices in non-U.S. countries are subject to political, economic, financial and social factors that may be unique to the particular country. These factors, which could negatively affect the non-U.S. securities markets, include the possibility of recent or future changes in the non-U.S. government’s economic and fiscal policies, the possible imposition of, or changes in, currency exchange laws or other non-U.S. laws or restrictions applicable to non-U.S. companies or investments in non-U.S. equity securities and the possibility of fluctuations in the rate of exchange between currencies. Moreover, certain aspects of a particular non-U.S. economy may differ favorably or unfavorably from the U.S. economy in important respects, such as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.

July 2025
Page 9

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Changes affecting the underlying index, including a change in law event, could have an adverse effect on the market value of, and any amount payable on, the Buffered PLUS. The policies of the index sponsor as specified under “Information About the Underlying Index” (the “index sponsor”), concerning additions, deletions and substitutions of the index constituent stocks and the manner in which the index sponsor takes account of certain changes affecting those index constituent stocks may adversely affect the value of the underlying index. The policies of the index sponsor with respect to the calculation of the underlying index could also adversely affect the value of the underlying index. The index sponsor may discontinue or suspend calculation or dissemination of the underlying index. Any such actions could have an adverse effect on the market value of, and any amount payable on, the Buffered PLUS.
Further, if a change in law event (as defined in the product supplement) occurs and the index sponsor does not take actions to comply with such law(s), the calculation agent may select a successor index or take other actions as discussed in the product supplement and, notwithstanding these adjustments, the market value of, and return on, the Buffered PLUS may be adversely affected.
There is no affiliation between the index sponsor and TD, and TD is not responsible for any disclosure by such index sponsor. We or our affiliates may currently, or from time to time engage in business with the index sponsor. However, we and our affiliates are not affiliated with the index sponsor and have no ability to control or predict its actions. You, as an investor in the Buffered PLUS, should conduct your own independent investigation of the index sponsor and the underlying index. The index sponsor is not involved in the Buffered PLUS offered hereby in any way and has no obligation of any sort with respect to your Buffered PLUS. The index sponsor has no obligation to take your interests into consideration for any reason, including when taking any actions that might affect the value of, and any amounts payable on, your Buffered PLUS.
Governmental regulatory actions, such as sanctions, could adversely affect your investment in the Buffered PLUS. Governmental regulatory actions, including, without limitation, sanctions-related actions by the U.S. or a foreign government, could prohibit or otherwise restrict persons from holding the Buffered PLUS or the index constituent stocks of the underlying index, or engaging in transactions therein, and any such action could adversely affect the value of the underlying index or the Buffered PLUS. These regulatory actions could result in restrictions on the Buffered PLUS and could result in the loss of a significant portion or all of your investment in the Buffered PLUS, including if you are forced to divest the Buffered PLUS due to the government mandates, especially if such divestment must be made at a time when the value of the Buffered PLUS has declined.
Risks Relating to Estimated Value and Liquidity
The estimated value of your Buffered PLUS is expected to be less than the public offering price of your Buffered PLUS. The estimated value of your Buffered PLUS on the pricing date is expected to be less than the public offering price of your Buffered PLUS. The difference between the public offering price of your Buffered PLUS and the estimated value of the Buffered PLUS reflects costs and expected profits associated with selling and structuring the Buffered PLUS, as well as hedging our obligations under the Buffered PLUS. Because hedging our obligations entails risks and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or a loss.
The estimated value of your Buffered PLUS is based on our internal funding rate. The estimated value of your Buffered PLUS on the pricing date is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated value of the Buffered PLUS generally represents a discount from the credit spreads for our conventional, fixed-rate debt Buffered PLUS and the borrowing rate we would pay for our conventional, fixed-rate debt Buffered PLUS. This discount is based on, among other things, our view of the funding value of the Buffered PLUS as well as the higher issuance, operational and ongoing liability management costs of the Buffered PLUS in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any hedge positions, taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt Buffered PLUS, or the borrowing rate we would pay for our conventional, fixed-rate debt Buffered PLUS were to be used, we would expect the economic terms of the Buffered PLUS to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Buffered PLUS is expected to increase the estimated value of the Buffered PLUS at any time.

July 2025
Page 10

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
The estimated value of the Buffered PLUS is based on our internal pricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions. The estimated value of your Buffered PLUS on the pricing date is based on our internal pricing models when the terms of the Buffered PLUS are set, which take into account a number of variables, such as our internal funding rate on the pricing date, and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other financial institutions’ pricing models and the methodologies used by us to estimate the value of the Buffered PLUS may not be consistent with those of other financial institutions that may be purchasers or sellers of Buffered PLUS in the secondary market. As a result, the secondary market price of your Buffered PLUS may be materially less than the estimated value of the Buffered PLUS determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be incorrect.
The estimated value of your Buffered PLUS is not a prediction of the prices at which you may sell your Buffered PLUS in the secondary market, if any, and such secondary market prices, if any, will likely be less than the public offering price of your Buffered PLUS and may be less than the estimated value of your Buffered PLUS. The estimated value of the Buffered PLUS is not a prediction of the prices at which the agent, other affiliates of ours or third parties may be willing to purchase the Buffered PLUS from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Buffered PLUS in the secondary market at any time, if any, will be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Buffered PLUS. Further, as secondary market prices of your Buffered PLUS take into account the levels at which our debt Buffered PLUS trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Buffered PLUS, as well as hedging our obligations under the Buffered PLUS, secondary market prices of your Buffered PLUS will likely be less than the public offering price of your Buffered PLUS. As a result, the price at which the agent, other affiliates of ours or third parties may be willing to purchase the Buffered PLUS from you in secondary market transactions, if any, will likely be less than the price you paid for your Buffered PLUS, and any sale prior to the maturity date could result in a substantial loss to you.
The temporary price at which the agent may initially buy the Buffered PLUS in the secondary market may not be indicative of future prices of your Buffered PLUS. Assuming that all relevant factors remain constant after the pricing date, the price at which the agent may initially buy or sell the Buffered PLUS in the secondary market (if the agent makes a market in the Buffered PLUS, which it is not obligated to do) may exceed the estimated value of the Buffered PLUS on the pricing date, as well as the secondary market value of the Buffered PLUS, for a temporary period after the original issue date of the Buffered PLUS, as discussed further under “Additional Information About the Buffered PLUS — Additional information regarding the estimated value of the Buffered PLUS”. The price at which the agent may initially buy or sell the Buffered PLUS in the secondary market may not be indicative of future prices of your Buffered PLUS.
The underwriting discount, offering expenses and certain hedging costs are likely to adversely affect secondary market prices. Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Buffered PLUS will likely be less than the public offering price. The public offering price includes, and any price quoted to you is likely to exclude, any underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under the Buffered PLUS. In addition, any such price is also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction.
There may not be an active trading market for the Buffered PLUS — sales in the secondary market may result in significant losses. There may be little or no secondary market for the Buffered PLUS. The Buffered PLUS will not be listed or displayed on any Buffered PLUS exchange or electronic communications network. The agent or another one of our affiliates may make a market for the Buffered PLUS; however, it is not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Buffered PLUS develops, it may not provide significant liquidity or trade at prices advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Buffered PLUS in any secondary market could be substantial. If you sell your Buffered PLUS before the maturity date, you may have to do so at a substantial discount from the public offering price irrespective of the price of the underlying index, and as a result, you may suffer substantial losses.

July 2025
Page 11

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
If the value of the underlying index changes, the market value of your Buffered PLUS may not change in the same manner. Your Buffered PLUS may trade quite differently from the performance of the underlying index. Changes in the value of the underlying index may not result in a comparable change in the market value of your Buffered PLUS. Even if the closing value of the underlying index increases to greater than the initial index value during the term of the Buffered PLUS, the market value of your Buffered PLUS may not increase by the same amount and could decline.
Risks Relating to General Credit Characteristics
Investors are subject to TD’s credit risk, and TD’s credit ratings and credit spreads may adversely affect the market value of the Buffered PLUS. Although the return on the Buffered PLUS will be based on the performance of the underlying index, the payment of any amount due on the Buffered PLUS is subject to TD’s credit risk. The Buffered PLUS are TD’s senior unsecured debt obligations. Investors are dependent on TD’s ability to pay all amounts due on the Buffered PLUS and, therefore, investors are subject to the credit risk of TD and to changes in the market’s view of TD’s creditworthiness. Any decrease in TD’s credit ratings or increase in the credit spreads charged by the market for taking TD’s credit risk is likely to adversely affect the market value of the Buffered PLUS. If TD becomes unable to meet its financial obligations as they become due, investors may not receive any amounts due under the terms of the Buffered PLUS.
Risks Relating to Hedging Activities and Conflicts of Interest
There are potential conflicts of interest between you and the calculation agent. The calculation agent will, among other things, determine the amount payable on the Buffered PLUS. We will serve as the calculation agent and may appoint a different calculation agent after the original issue date without notice to you. The calculation agent will exercise its judgment when performing its functions and may have a conflict of interest if it needs to make certain decisions. For example, the calculation agent may have to determine whether a market disruption event affecting the underlying index has occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the calculation agent’s judgment as to whether the event has materially interfered with our ability or the ability of one of our affiliates to unwind our hedge positions. Because this determination by the calculation agent may affect the return on the Buffered PLUS, the calculation agent may have a conflict of interest if it needs to make a determination of this kind. For additional information on the calculation agent’s role, see “General Terms of the Notes — Role of Calculation Agent” in the product supplement.
The valuation date, and therefore the maturity date, are subject to market disruption events and postponements. The valuation date, and therefore the maturity date, are subject to postponement as described in the product supplement due to the occurrence of one or more market disruption events. For a description of what constitutes a market disruption event as well as the consequences of that market disruption event, see “General Terms of the Notes—Market Disruption Events” in the product supplement.
Trading and business activities by TD or its affiliates may adversely affect the market value of, and return on, the Buffered PLUS. We, the agent and/or our other affiliates may hedge our obligations under the Buffered PLUS by purchasing securities, futures, options or other derivative instruments with returns linked or related to changes in the value of the underlying index or one or more index constituent stocks, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is possible that we or one or more of our affiliates could receive substantial returns from these hedging activities while the market value of the Buffered PLUS declines. We or one or more of our affiliates may also issue or underwrite other securities or financial or derivative instruments with returns linked or related to changes in the underlying index or one or more index constituent stocks.
These trading activities may present a conflict between the holders’ interest in the Buffered PLUS and the interests we and our affiliates will have in our or their proprietary accounts, in facilitating transactions, including options and other derivatives transactions, for our or their customers’ accounts and in accounts under our or their management. These trading activities could be adverse to the interests of the holders of the Buffered PLUS.
We, the agent and/or our other affiliates may, at present or in the future, engage in business with one or more underlying index Constituent Issuers, including making loans to or providing advisory services to those companies. These services could include investment banking and merger and acquisition advisory services. These business activities may present a conflict between our, the agent’s and/or our other affiliates’ obligations, and your interests as a holder of the Buffered PLUS. Moreover, we, the agent and/or our other affiliates may have published, and in the future expect to publish, research reports with respect to the underlying index or one or more index constituent stocks. This research is modified from time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding the Buffered PLUS. Any of these activities by us and/or our other affiliates may affect the value of the underlying index and, therefore, the market value of, and return on, the Buffered PLUS.

July 2025
Page 12

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Risks Relating to Canadian and U.S. Federal Income Taxation
Significant aspects of the tax treatment of the Buffered PLUS are uncertain. Significant aspects of the U.S. tax treatment of the Buffered PLUS are uncertain. You should read carefully the section entitled “Material U.S. federal income tax consequences” herein and in the product supplement. You should consult your tax advisor as to the tax consequences of your investment in the Buffered PLUS.
For a discussion of the Canadian federal income tax consequences of investing in the Buffered PLUS, please see the discussion in the prospectus under “Tax Consequences – Canadian Taxation” and in the product supplement under “Supplemental Discussion of Canadian Tax Consequences” and the further discussion herein under “Additional Information About the Buffered PLUS”. If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal income tax purposes or if you acquire the Buffered PLUS in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Buffered PLUS and receiving the payment that might be due under the Buffered PLUS.

July 2025
Page 13

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Information About the Underlying Index
All disclosures contained in this document regarding the underlying index are derived from publicly available information. TD has not conducted any independent review or due diligence of any publicly available information with respect to the underlying index. You should make your own investigation into the underlying index.
EURO STOXX 50® Index
We have derived all information regarding the EURO STOXX 50® Index (“SX5E”) contained in this document, including, without limitation, its make‑up, method of calculation and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by STOXX Limited (its “Index Sponsor” or “STOXX”).
SX5E is published by STOXX, but STOXX has no obligation to continue to publish SX5E, and may discontinue publication of SX5E at any time. SX5E is determined, comprised and calculated by STOXX without regard to this instrument.
As discussed more fully in the underlier supplement under the heading “Indices — The EURO STOXX 50® Index”, SX5E covers 50 stocks of market sector leaders mainly from 8 Eurozone countries: Belgium, Finland, France, Germany, Ireland, Italy, the Netherlands and Spain. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor on its website.
Information as of market close on July 14, 2025:
Bloomberg Ticker Symbol:
SX5E <Index>
52 Week High (on March 3, 2025):
5,540.69
Current Index Value:
5,370.85
52 Week Low (on August 5, 2024):
4,571.60
52 Weeks Ago (on July 12, 2024):
5,043.02



July 2025
Page 14

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Historical Information
The table below sets forth the published high and low index closing values, as well as the end-of-quarter index closing values, of the underlying index for the specified period. The index closing value of the underlying index on July 14, 2025 was 5,370.85. The graph below sets forth the index closing values of the underlying index for each day from January 1, 2020 through July 14, 2025. We obtained the information in the table below from Bloomberg Professional® service (“Bloomberg”), without independent verification. TD has not undertaken an independent review or due diligence of any publicly available information obtained from Bloomberg. The historical performance of the underlying index should not be taken as an indication of its future performance, and no assurance can be given as to the index closing value of the underlying index at any time, including the valuation date.
EURO STOXX 50® Index
High
Low
Period End
2020
     
First Quarter
3,865.18
2,385.82
2,786.90
Second Quarter
3,384.29
2,662.99
3,234.07
Third Quarter
3,405.35
3,137.06
3,193.61
Fourth Quarter
3,581.37
2,958.21
3,552.64
2021
     
First Quarter
3,926.20
3,481.44
3,919.21
Second Quarter
4,158.14
3,924.80
4,064.30
Third Quarter
4,246.13
3,928.53
4,048.08
Fourth Quarter
4,401.49
3,996.41
4,298.41
2022
     
First Quarter
4,392.15
3,505.29
3,902.52
Second Quarter
3,951.12
3,427.91
3,454.86
Third Quarter
3,805.22
3,279.04
3,318.20
Fourth Quarter
3,986.83
3,331.53
3,793.62
2023
     
First Quarter
4,315.05
3,856.09
4,315.05
Second Quarter
4,408.59
4,218.04
4,399.09
Third Quarter
4,471.31
4,129.18
4,174.66
Fourth Quarter
4,549.44
4,014.36
4,521.44
2024
     
First Quarter
5,083.42
4,403.08
5,083.42
Second Quarter
5,100.90
4,839.14
4,894.02
Third Quarter
5,067.45
4,571.60
5,000.45
Fourth Quarter
5,041.01
4,729.71
4,895.98
2025
     
First Quarter
5,540.69
4,871.45
5,248.39
Second Quarter
5,454.65
4,622.14
5,303.24
Third Quarter (through July 14, 2025)
5,454.65
5,282.43
5,370.85

July 2025
Page 15

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
EURO STOXX 50® Index – Daily Index Closing Values
January 1, 2020 to July 14, 2025

This document relates only to the Buffered PLUS offered hereby and does not relate to the underlying index or other securities linked to the underlying index. We have derived all disclosures contained in this document regarding the underlying index from the publicly available documents described in the preceding paragraphs. In connection with the offering of the Buffered PLUS, none of us or any of our affiliates have participated in the preparation of such documents or made any due diligence inquiry with respect to the underlying index.
Neither the issuer nor any of its affiliates makes any representation to you as to the performance of the underlying index.

July 2025
Page 16

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
Additional Information About the Buffered PLUS
Please read this information in conjunction with the summary terms on the front cover of this document.
 
Additional Provisions:
 
 
Trustee:
The Bank of New York
 
 
Calculation agent:
TD
 
 
Trading day:
As specified in the product supplement under “General Terms of the Notes — Special Calculation Provisions — Trading Day”.
 
 
Business day:
Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized or required by law to close in New York City.
 
 
Canadian bail-in:
The Buffered PLUS are not bail-inable debt securities under the CDIC Act.
 
 
Change in law event:
Applicable, as described in the product supplement
 
 
Terms incorporated:
All of the terms appearing above the item under the caption “General Terms of the Notes” in the accompanying product supplement, as modified by this document, and for purposes of the foregoing, the terms used herein mean the corresponding terms as defined in the accompanying product supplement, as specified below:
 
Term used herein
Corresponding term in the
accompanying product supplement
 
underlying index
reference asset
 
index constituent stocks
reference asset constituents
 
stated principal amount
principal amount
 
original issue date
issue date
 
valuation date
final valuation date
 
index closing value
closing level
 
initial index value
initial level
 
final index value
final level
 
buffer amount
buffer percentage
 
underlying return
percentage change
 
 
Additional information regarding the
estimated value of the Buffered PLUS:
The final terms for the Buffered PLUS will be determined on the date the Buffered PLUS are initially priced for sale to the public, which we refer to as the pricing date, based on prevailing market conditions, and will be communicated to investors in the final pricing supplement.
The economic terms of the Buffered PLUS are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and our appetite for borrowing), and several factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection with structuring the Buffered PLUS, estimated costs which we may incur in connection with the Buffered PLUS and the estimated cost which we may incur in hedging our obligations under the Buffered PLUS. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt Buffered PLUS trade in the secondary market, the use of an internal funding rate for the Buffered PLUS rather than the levels at which our benchmark debt Buffered PLUS trade in the secondary market is expected to have an adverse effect on the economic terms of the Buffered PLUS.
On the cover page of this pricing supplement, we have provided the estimated value range for the Buffered PLUS. The estimated value range was determined by reference to our internal pricing models which take into account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates), price-sensitivity analysis, time to maturity of the Buffered PLUS and our internal funding rate. For more information about the estimated value, see “Risk Factors — Risks Relating to Estimated Value and Liquidity” herein. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt Buffered PLUS trade in the secondary market, the use of an internal funding rate for the Buffered PLUS rather than the levels at which our benchmark debt Buffered PLUS
 

July 2025
Page 17

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
 
trade in the secondary market is expected, assuming all other economic terms are held constant, to increase the estimated value of the Buffered PLUS. For more information see the discussion under “Risk Factors — Risks Relating to Estimated Value and Liquidity — The estimated value of your Buffered PLUS is based on our internal funding rate”.
Our estimated value on the pricing date is not a prediction of the price at which the Buffered PLUS may trade in the secondary market, nor will it be the price at which the agent may buy or sell the Buffered PLUS in the secondary market. Subject to normal market and funding conditions, the agent or another affiliate of ours intends to offer to purchase the Buffered PLUS in the secondary market but it is not obligated to do so.
Assuming that all relevant factors remain constant after the pricing date, the price at which the agent may initially buy or sell the Buffered PLUS in the secondary market, if any, may exceed our estimated value on the pricing date for a temporary period expected to be approximately 6 weeks after the original issue date because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under the Buffered PLUS and other costs in connection with the Buffered PLUS which we will no longer expect to incur over the term of the Buffered PLUS. We made such discretionary election and determined this temporary reimbursement period on the basis of a number of factors, including the tenor of the Buffered PLUS and any agreement we may have with the distributors of the Buffered PLUS. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the original issue date of the Buffered PLUS based on changes in market conditions and other factors that cannot be predicted.
We urge you to read the “Risk Factors” in this pricing supplement for additional information.
 
 
Material Canadian income tax
consequences:
Please see the discussion in the prospectus under “Tax Consequences – Canadian Taxation” and in the product supplement under “Supplemental Discussion of Canadian Tax Consequences”, which applies to the Buffered PLUS. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax Act (as defined in the prospectus).
 
 
Material U.S. federal income tax
consequences:
The U.S. federal income tax consequences of your investment in the Buffered PLUS are uncertain. There are no statutory provisions, regulations, published rulings or judicial decisions addressing the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the Buffered PLUS. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion in “Material U.S. Federal Income Tax Consequences”, in the accompanying product supplement and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the “Code”), final, temporary and proposed U.S. Department of the Treasury (the “Treasury”) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the “IRS”) has been sought as to the U.S. federal income tax consequences of your investment in the Buffered PLUS, and the following discussion is not binding on the IRS.
U.S. Tax Treatment. Pursuant to the terms of the Buffered PLUS, TD and you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to characterize your Buffered PLUS as prepaid derivative contracts with respect to the underlying index. If your Buffered PLUS are so treated, you should generally recognize long-term capital gain or loss if you hold your Buffered PLUS for more than one year (and, otherwise, short-term capital gain or loss) upon the taxable disposition (including cash settlement) of your Buffered PLUS, in an amount equal to the difference between the amount you receive at such time and the amount you paid for your Buffered PLUS. The deductibility of capital losses is subject to limitations.
Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver & Jacobson LLP, is of the opinion that it would be reasonable to treat your Buffered PLUS in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Buffered PLUS, it is possible that your Buffered PLUS could alternatively be treated for tax purposes as a single contingent payment debt
 

July 2025
Page 18

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
 
instrument, or pursuant to some other characterization, such that the timing and character of your income from the Buffered PLUS could differ materially and adversely from the treatment described above, as described further under “Material U.S. Federal Income Tax Consequences”, in the accompanying product supplement. There may be also a risk that the IRS could assert that the Buffered PLUS should not give rise to long-term capital gain or loss because the Buffered PLUS offer, at least in part, short exposure to the underlying index.
Section 1297. We will not attempt to ascertain whether any index constituent stock issuer would be treated as a “passive foreign investment company” (a “PFIC”) within the meaning of Section 1297 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply to U.S. holders upon the taxable disposition (including cash settlement) of a security. U.S. holders should refer to information filed with the SEC or the equivalent governmental authority by such entities and consult their tax advisors regarding the possible consequences to them if any such entity is or becomes a PFIC.
Except to the extent otherwise required by law, TD intends to treat your Buffered PLUS for U.S. federal income tax purposes in accordance with the treatment described above and under “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.
Notice 2008-2. In 2007, the IRS released a notice that may affect the taxation of holders of the Buffered PLUS. According to Notice 2008-2, the IRS and the Treasury are considering whether a holder of an instrument such as the Buffered PLUS should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that under such guidance, holders of the Buffered PLUS will ultimately be required to accrue income currently and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special “constructive ownership rules” of Section 1260 of the Code should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations.
Medicare Tax on Net Investment Income. U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion of their “net investment income,” or “undistributed net investment income” in the case of an estate or trust, which may include any income or gain realized with respect to the Buffered PLUS, to the extent of their net investment income or undistributed net investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders should consult their tax advisors as to the consequences of the 3.8% Medicare tax.
Specified Foreign Financial Assets. Certain U.S. holders that own “specified foreign financial assets” in excess of an applicable threshold may be subject to reporting obligations with respect to such assets with their tax returns, especially if such assets are held outside the custody of a U.S. financial institution. U.S. holders are urged to consult their tax advisors as to the application of this legislation to their ownership of the Buffered PLUS.
Non-U.S. Holders. Subject to Section 871(m) of the Code and “FATCA”, discussed below, if the Buffered PLUS are offered to non-U.S. holders, you should generally not be subject to U.S. withholding tax with respect to payments on your Buffered PLUS or to generally applicable information reporting and backup withholding requirements with respect to payments on your Buffered PLUS if you comply with certain certification and identification requirements as to your non-U.S. status (by providing us (and/or the applicable withholding agent) with a fully completed and duly executed applicable IRS Form W-8). Subject to Section 871(m) of the Code, discussed below, gain realized from the taxable disposition of a Buffered PLUS generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by you in the U.S., (ii) you are a non-resident alien individual and are present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) you have certain other present or former connections with the U.S.
Section 871(m). A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain “dividend
 

July 2025
Page 19

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
 
equivalents” paid or deemed paid to a non-U.S. holder with respect to a “specified equity-linked instrument” that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that have a delta of one (“delta-one specified equity-linked instruments”) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not delta-one specified equity-linked instruments and are issued before January 1, 2027.
Based on the nature of the underlying index and our determination that the Buffered PLUS are not “delta-one” with respect to the underlying index or any index constituent stocks, our special U.S. tax counsel is of the opinion that the Buffered PLUS should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the Buffered PLUS are set. If withholding is required, we will not make payments of any additional amounts.
Nevertheless, after the date the terms are set, it is possible that your Buffered PLUS could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the underlying index, any index constituent stocks or your Buffered PLUS, and following such occurrence your Buffered PLUS could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax or other tax under Section 871(m) of the Code could apply to the Buffered PLUS under these rules. If you enter, or have entered, into other transactions in respect of the underlying index, any index constituent stocks or the Buffered PLUS should consult your tax advisor regarding the application of Section 871(m) of the Code to your Buffered PLUS in the context of your other transactions.
Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the Buffered PLUS, you are urged to consult your tax advisor regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the Buffered PLUS.
FATCA. The Foreign Account Tax Compliance Act (“FATCA”) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on “withholdable payments” (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical gain, profits and income, and the gross proceeds from a disposition of property of a type which can produce U.S.-source interest or dividends) and “passthru payments” (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign financial institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA also requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any substantial U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.
Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain “withholdable payments”, will not apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term “foreign passthru payment” are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.
Investors should consult their tax advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their Buffered PLUS through a foreign entity) under the FATCA rules.
Backup Withholding and Information Reporting. The proceeds received from a taxable
 

July 2025
Page 20

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities

 
disposition of the Buffered PLUS will be subject to information reporting unless you are an “exempt recipient” and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a U.S. holder) or meet certain other conditions.
Amounts withheld under the backup withholding rules are not additional taxes and may be refunded or credited against your U.S. federal income tax liability, provided the required information is furnished to the IRS.
U.S. Federal Estate Tax Treatment of Non-U.S. Holders. A Buffered PLUS may be subject to U.S. federal estate tax if an individual non-U.S. holder holds the Buffered PLUS at the time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the U.S. federal estate tax consequences of holding the Buffered PLUS at death.
Proposed Legislation. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of the Buffered PLUS purchased after the bill was enacted to accrue interest income over the term of the Buffered PLUS despite the fact that there will be no interest payments over the term of the Buffered PLUS.
Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation generally would have been to require instruments such as the Buffered PLUS to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.
It is not possible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Buffered PLUS. You are urged to consult your tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Buffered PLUS.
Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the application of U.S. federal income tax laws to their particular situations, as well as any tax consequences of the purchase, beneficial ownership and disposition of the Buffered PLUS arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD and those of the index constituent stock issuers).
 
 
Supplemental information regarding
plan of distribution (conflicts of
interest); secondary markets (if any):
We have appointed TDS, an affiliate of TD, as the agent for the sale of the Buffered PLUS. Pursuant to the terms of a distribution agreement, TDS will purchase the Buffered PLUS from TD at the price to public less a fee of $25.00 per Buffered PLUS. TDS will resell all of the Buffered PLUS to Morgan Stanley Wealth Management with an underwriting discount of $25.00 reflecting a fixed sales commission of $20.00 and fixed structuring fee of $5.00 per $1,000.00 stated principal amount of Buffered PLUS that Morgan Stanley Wealth Management sells. TD or an affiliate will also pay a fee to LFT Securities, LLC, an entity in which TD and an affiliate of Morgan Stanley Wealth Management have an ownership interest, for providing certain electronic platform services with respect to this offering.
 
 
Conflicts of Interest TDS is an affiliate of TD and, as such, has a ‘‘conflict of interest’’ in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (“FINRA”) Rule 5121. If any other affiliate of TD participates in this offering, that affiliate will also have a “conflict of interest” within the meaning of FINRA Rule 5121. In addition, TD will receive the net proceeds from the initial public offering of the Buffered PLUS, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of the Buffered PLUS will be conducted in compliance with the provisions of FINRA Rule 5121. In accordance with FINRA Rule 5121, neither TDS nor any other affiliate of ours is permitted to sell the Buffered PLUS in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.
We, TDS, another of our affiliates or third parties may use this pricing supplement in the initial sale of the Buffered PLUS. In addition, we, TDS, another of our affiliates or third parties may use this pricing supplement in a market-making transaction in the Buffered PLUS after their initial sale. If a purchaser buys the Buffered PLUS from us, TDS, another of our affiliates or third parties, this pricing supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or third parties informs such purchaser otherwise in the confirmation of sale.
 

July 2025
Page 21

Dual Directional Buffered PLUS Based on the Value of the EURO STOXX 50® Index due August 4, 2027
Buffered Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
 
Prohibition of sales in Canada and to
Canadian residents:
The Buffered PLUS may not be offered, sold or otherwise made available directly or indirectly in Canada or to any resident of Canada.
 
 
Prohibition on sales to EEA retail
investors:
The Buffered PLUS are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the “EEA”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended. Consequently no key information document required by Regulation (EU) No 1286/2014 (the “PRIIPs Regulation”), for offering or selling the Buffered PLUS or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Buffered PLUS or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation.
 
 
Prohibition on sales to United Kingdom
retail investors:
The Buffered PLUS are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (“UK”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the “EUWA”); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the “FSMA”) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling the Buffered PLUS or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Buffered PLUS or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.
 


July 2025
Page 22

FAQ

What is the coupon rate on UBS's Trigger Callable Contingent Yield Notes?

The notes pay a contingent coupon of 8.85 % per annum, credited monthly when all three indices are at or above 70 % of their initial levels.

When can UBS call the WUCT 424B2 notes?

UBS may call the notes on any monthly observation date after six months; if called, holders receive par plus the relevant coupon.

How much principal protection do the notes provide?

Full principal is repaid only if each index stays ≥ 70 % of its initial level at maturity; otherwise investors incur the full negative return of the worst index.

What is the estimated initial value versus the issue price?

UBS calculates an estimated initial value of $964.20 per $1,000 note, implying about 3.6 % in embedded fees and hedging costs.

Are the notes listed on an exchange?

No. The notes will not be listed; any liquidity will depend on UBS or affiliates making a secondary market, which they are not obligated to do.

Which indices determine performance of these contingent yield notes?

Performance is linked to the Dow Jones Industrial Average, Nasdaq-100 Technology Sector Index, and Russell 2000 Index.
Toronto Domin

NYSE:TD

TD Rankings

TD Latest News

TD Latest SEC Filings

TD Stock Data

127.53B
1.72B
0.02%
53.94%
0.67%
Banks - Diversified
Financial Services
Link
Canada
Toronto